Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study

Araki T, Putman RK, Hatabu H, Gao W, Dupuis J ee, Latourelle JC, Nishino M, Zazueta OE, Kurugol S, Ross JC, et al. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016;194(12):1514–1522.

Abstract

RATIONALE: The relationship between the development and/or progression of interstitial lung abnormalities (ILA) and clinical outcomes has not been previously investigated. OBJECTIVES: To determine the risk factors for, and the clinical consequences of, having ILA progression in participants from the Framingham Heart Study. METHODS: ILA were assessed in 1,867 participants who had serial chest computed tomography (CT) scans approximately 6 years apart. Mixed effect regression (and Cox) models were used to assess the association between ILA progression and pulmonary function decline (and mortality).
Last updated on 02/26/2023